Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Infectious Diseases”

23,468 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 23,468 results

Large-scale testing (Phase 3)Study completedNCT00234910
What this trial is testing

Efficacy of Simplified Two Drug Kaletra Regimen vs. Kaletra Triple Drug Standard of Care Regimen in Treatment naïve HIV Infected Patients

Who this might be right for
HIV Infection
Abbott 152
Post-approval studies (Phase 4)Active Not RecruitingNCT04032860
What this trial is testing

RCT of Different Effects of Nucleot(s)Ide Analogues on the Prognosis of HBV-HCC Patients After Curative Resection

Who this might be right for
HCCHBV Coinfection
West China Hospital 104
Early research (Phase 1)Study completedNCT02132260
What this trial is testing

Evaluate the Safety and Efficacy of Naftifine Hydrochloride Cream 2% and Naftin® Cream 2% in Patients With Tinea Pedis

Who this might be right for
Tinea Pedis
Sun Pharmaceutical Industries, Inc. 890
Large-scale testing (Phase 3)Study completedNCT00443820
What this trial is testing

Efficacy Safety, and Tolerability of Topical Terbinafine in Patients With Mild to Moderate Toenail Fungus of the Big Toenail

Who this might be right for
Onychomycosis
Novartis Pharmaceuticals 526
Early research (Phase 1)Ended earlyNCT02289482
What this trial is testing

A Single Dose Pharmacokinetic (PK) and Safety Study of GSK2838232 With and Without Ritonavir (RTV) Conducted in Healthy Subjects

Who this might be right for
Infection, Human Immunodeficiency Virus
GlaxoSmithKline 20
Not applicableStudy completedNCT02630082
What this trial is testing

Feasibility of Measuring Immune Resp, Activation in Foreskin/Mucosa in HIV-, Uncircumcised High-HIV-risk MSM, Lima Peru

Who this might be right for
HIV InfectionsAcquired Immunodeficiency SyndromeLentivirus Infections+8 more
National Institute of Allergy and Infectious Diseases (NIAID) 29
Early research (Phase 1)WithdrawnNCT06533280
What this trial is testing

VH3739937 Phase 1 Multiple Ascending Dose (MAD) Study in Healthy Volunteers Including Relative Bioavailability (RBA), Optional Food Effect (FE), and Drug-drug Interaction (DDI)

Who this might be right for
HIV Infections
ViiV Healthcare
Not applicableStudy completedNCT02953080
What this trial is testing

Improving Outcomes in HIV Patients Using Mobile Phone Based Interactive Software Support

Who this might be right for
Human Immunodeficiency Virus
Makerere University 600
Post-approval studies (Phase 4)Study completedNCT00338780
What this trial is testing

Trial of Lamivudine Treatment in HBeAg Negative Chronic Hepatitis B Patients (in Asia)

Who this might be right for
Chronic Hepatitis B
Chinese University of Hong Kong
Not applicableWithdrawnNCT00700362
What this trial is testing

Insulin Infusion and Infectious Diabetic Foot Ulcers (IIIFU)

Who this might be right for
Diabetes MellitusInsulin ResistanceHyperglycemia+1 more
Karolinska Institutet
Not applicableUnknownNCT04339127
What this trial is testing

Autoimmune Encephalitis With Anti-NMDA Receptor Antibodies Following Herpetic Encephalitis

Who this might be right for
Autoimmune EncephalitisAnti NMDA Receptor EncephalitisHerpetic Encephalitis
Hospices Civils de Lyon 12
Testing effectiveness (Phase 2)Study completedNCT00433069
What this trial is testing

Retreatment of Chronic Hepatitis C Non-responders With Pegylated Interferon Alpha Plus Ribavirin Plus Pioglitazone

Who this might be right for
Chronic Hepatitis C
University Hospital, Geneva 5
Post-approval studies (Phase 4)Ended earlyNCT02429583
What this trial is testing

Effects of Persistent Innate Immune Activation on Vaccine Efficacy

Who this might be right for
Hepatitis C Infection
Rockefeller University 24
Testing effectiveness (Phase 2)UnknownNCT06282783
What this trial is testing

Studying Topiramate for Re-Activating the HIV-1 Reservoir

Who this might be right for
HIV-1-infectionHivHIV Infections+1 more
Erasmus Medical Center 12
Not applicableWithdrawnNCT01691235
What this trial is testing

SIMpill Medication Dispensing Device in the Treatment of HCV

Who this might be right for
Chronic Hepatitis C Virus
University of Chicago
Testing effectiveness (Phase 2)Study completedNCT01935635
What this trial is testing

A Clinical Trial on HB-Vac Activated-DCs Combined With Peg-IFN or NAs in CHB

Who this might be right for
Chronic Hepatitis B
Third Affiliated Hospital, Sun Yat-Sen University 400
Not applicableStudy completedNCT01099943
What this trial is testing

Reducing Inappropriate Antibiotic Prescribing by Primary Care Clinicians

Who this might be right for
Increased Drug ResistanceInfectious Diseases
University of Colorado, Denver 8
Testing effectiveness (Phase 2)Ended earlyNCT02759315
What this trial is testing

Efficacy and Safety of Uprifosbuvir (MK-3682) With Ruzasvir (MK-8408) in Adults With Chronic Hepatitis C Genotype 1, 2, 3, 4, 5 or 6 Infection (MK-3682-035)

Who this might be right for
Hepatitis C, Chronic
Merck Sharp & Dohme LLC 160
Not applicableUnknownNCT03753308
What this trial is testing

Mechanism of DCs Dysfunction in Chronic HBV Infection

Who this might be right for
HBVNASH - Nonalcoholic Steatohepatitis
University Hospital, Grenoble 132
Not applicableStudy completedNCT00026676
What this trial is testing

Correlation of HIV Levels With Clinical and Immunologic Outcome in Children Treated With Didanosine

Who this might be right for
HIV Infection
National Cancer Institute (NCI) 82
Load More Results